Mitobridge is a biotech company that discovers and develops small molecule modulators to improve mitochondrial functions. They are utilizing advanced technologies to develop a unique drug discovery platform for the identification and evaluation of compounds that effectively improve mitochondrial functions or correct mitochondrial dysfunctions. Their strategy is to produce drug candidates that have the potential to treat a wide range of medical conditions, including rare diseases and conditions that affect large patient populations. Mitobridge has an experienced management and scientific team with a proven track record for discovering ground-breaking drugs and building successful biotech companies.